A weak spot found in tough cancer cells
Original title: Txn-Txnrd1 system supports redox rewiring during polyaneuploid transition and protects giant cancer cell at new redox homeostasis
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was done on cells in the lab, not in people.
The short version
In lab tests, blocking one system killed cancer cells that usually survive treatment.
What was studied. Researchers studied giant cancer cells that live through drug treatment and can bring a tumor back. They tested what keeps these cells alive, then checked gene patterns in patient tumor data.
What they found. The giant cells shift how they handle stress inside the cell. They lean on a system called Txn-Txnrd1 to stay alive under that stress. When the researchers blocked or shut down that system, large numbers of these cells died. In patient tumor data, high levels of these genes went along with worse outcomes and a weaker response to chemotherapy in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary and intestinal cancer.
What this means, and what it doesn't
What it could mean: This points to a possible new target for future drugs. If it holds up, it might one day help stop tumors that come back after treatment. For now it is a clue for researchers, not a treatment you can ask for.
What it doesn't mean: This is early lab work on cells, not a treatment tested in people. No patient was given a drug in this study. It does not mean a cure, and it does not change the care you get today. Many findings like this never become a treatment.
Source: bioRxiv (preprint), August 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.